Market revenue in 2023 | USD 985.8 million |
Market revenue in 2030 | USD 1,579.2 million |
Growth rate | 7% (CAGR from 2023 to 2030) |
Largest segment | Latex |
Fastest growing segment | Non-latex |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Latex, Non-latex |
Key market players worldwide | Reckitt Benckiser Group PLC, Church & Dwight Co Inc, Veru Inc, Pasante Healthcare, Mankind Pharma, Sagami Rubber Industries, Fuji Latex, karex, Okamoto Industries, LELO, TruArc Partners, Cupid, JOM Group |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to condom market will help companies and investors design strategic landscapes.
Latex was the largest segment with a revenue share of 88.77% in 2023. Horizon Databook has segmented the Japan condom market based on latex, non-latex covering the revenue growth of each sub-segment from 2018 to 2030.
Condoms have been used since the 19th century in Japan when they were imported from France and England, and their production began in 1909 in the country. The trend of using condoms is high, and the providers are majorly local manufacturers, as there is a stringent regulatory approval process for marketing of foreign brands.
One of the restraining factors for foreign brands is the fact that they do not manufacture Asian-sized condoms that are generally smaller in size as compared to western condoms. However, the Japanese consumer demand for larger-sized condoms is growing as compared to traditional smaller condoms, due to change in diet for the past several decades.
Moreover, innovation in products is contributing to the entry of foreign manufacturers. For instance, VivaGel condom, manufactured by Australia-based Starpharma, which contains lubricant gel proven to kill HIV, was launched in Japan in June 2019.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan condom market , including forecasts for subscribers. This country databook contains high-level insights into Japan condom market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account